Methicillin-resistant Staphylococcus pseudintermedius (MRSP) has emerged as a highly 23 drug-resistant small animal veterinary pathogen. Although often isolated from 24 outpatients in veterinary clinics, there is concern that MRSP follows a veterinary-25 hospital-associated epidemiology. This study's objective was to identify risk factors for 26 MRSP infections in dogs and cats in Germany. Clinical isolates of MRSP cases (n=150) 27 and methicillin-susceptible S. pseudintermedius (MSSP) controls (n=133) 
Introduction 46
Staphylococcus pseudintermedius, belonging to the Staphylococcus intermedius groupis a frequent opportunistic commensal and the most important staphylococcal pathogen 48 in dogs and cats and frequently affects the skin, ears and wounds (Devriese et al., 2005; 49 Holm et al., 2002; White et al., 2005) . Until recently, treatment of the great majority of 50 S. pseudintermedius infections caused few problems in small animal veterinary practice 51 as a wide range of authorized antimicrobial drugs showed good efficacy both in vitro 52 and in vivo (Beco et al., 2012; Lloyd et al., 1996; Pellerin et al., 1998; Rantala et al., 53 2004) . However, the emergence of methicillin-resistant S. pseudintermedius (MRSP) 54 over the past ten years and its continuing spread worldwide (Gortel et al., 1999; Jones et 55 al., 2007; Morris et al., 2006; Loeffler et al., 2007; Ruscher et al., 2009) , present 56 significant clinical challenges to veterinary surgeons. In addition, MRSP has 57 implications for public health as it can spread between people and pets via direct and 58 indirect contact and rarely MRSP infections in humans have been described 59 (Campagnile et al., 2007; Gerstadt et al., 1999; Stegmann et al., 2010; van Duijkeren et 60 al., 2011 a & b) . 61
Resistance to methicillin in staphylococci is encoded by the gene mecA which confers 62 resistance to all β-lactam antibiotics (Chambers, 1997) . Epidemiologically, the 63 significance of mecA-positive staphylococci is greatest in the context of nosocomial 64 infections. Such isolates are likely to emerge as a consequence of antimicrobial 65 selection pressure in hospitals and are typically multidrug-resistant. In MRSP, several 66 other resistance genes have been identified which often render all clinically relevant pet-67 authorized systemic antimicrobial drugs ineffective (Kadlec and Schwarz, 2012) . For 68 canine pyoderma, it has been shown that most MRSP infections can still be resolved 69 7 laboratories included assessment of colony morphology and haemolysis on sheep blood 140 agar, the detection of clumping factor by slide coagulation test with rabbit plasma or by 141 a commercial agglutination test (Pasteurex Staph Plus®, Bio-Rad, Munich, Germany) 142 and a Voges-Proskauer-reaction. As all SIG isolates had originated from dogs or cats, 143 they were assumed to represent S. pseudintermedius (Bannoehr and Guardabassi, 144 2012) . Resistance to methicillin and antimicrobial agents commonly used for therapy in 145 small animal patients was determined through disc diffusion tests using oxacillin (OX 1 146 C Mast Diagnostica GmbH, Reinfeld, Germany) on Mueller-Hinton agar (Merck, 147 Darmstadt, Germany) or with MRSA-Ident-Agar (Heipha, Eppelheim, Germany) and 148 with VITEK2 (Biomérieux, Nürtingen, Germany). Breakpoints for disc diffusion tests 149 were according to Din 58940-3, supplement 1 (DIN, 2011) . 150
All S. pseudintermedius isolates were re-grown at the end of the enrolment period and 151 posted to the Royal Veterinary College on nutrient agar slopes or plates. Phenotypic 152 tests for initial genus and species identification were repeated from subcultures on 5% 153 ovine blood agar (Oxoid, Basingstoke, UK) as previously described (Loeffler et al., 154 2007) . The identity of MRSP isolates was confirmed phenotypically after growth on 155 mannitol salt agar containing 4% oxacillin (MSAox) (Oxoid, Basingstoke, UK) and 156 genotypically through demonstration of mecA after polymerase chain reaction (Brakstad 157 et al., 1993) . In addition, methicillin-resistant isolates were differentiated genetically 158 from non-pigmented strains of MRSA by demonstration of the S. intermedius-159 groupthermonuclease gene, nuc (Becker et al., 2005) , and those negative for S. 160
intermedius-group nuc were tested for S. aureus-specific nuc (Baron et al., 2004 This study confirms that MRSP should be regarded as a hospital-associated pathogen in 252 small animal veterinary practice and it provides data that emphasise the need for 253 rigorous hygiene measures and awareness of MRSP as an important contagion. 254
The estimates reported here need to be interpreted with caution for categories where 255 numbers were low, e.g. cats. An additional bias may have been introduced by the higher 256 questionnaire return rate from control animals. This could be due to concern over 257 certain clinics becoming associated with multidrug-resistance. with a large confidence interval, cats showed a substantially increased risk for MRSP 283 infection though, which may imply that infection in cats is indeed more likely to be of 284 hospital-or clinic related origin. 285
Systemic glucocorticoid therapy was shown to predispose to MRSP carriage in dogs in 286 both the present and in a previous study (Nienhoff et al., 2011a) . Since allergic skin 287 disease and the associated skin barrier dysfunction is known to favour staphylococcal 288 infection in dogs, and since allergy is commonly managed with gluocorticoids, it is 289 perhaps possible that glucocorticoid therapy favoured MRSP indirectly through the 290 need for repeated antimicrobial therapy and visits to veterinary clinics. 291
The lack of positive association between MRSP and antimicrobial therapy in the final 292 model was surprising in view of the more frequent antimicrobial prescription to MRSP 293 animals found in the univariable analysis. However, the link between antimicrobial 294 therapy and MRSP infection has not always been reported consistently. Antimicrobial 295 drug therapy was the most important risk factor for methicillin-resistance in 296 staphylococci in dogs with superficial pyoderma (Eckholm et al., 2013) and in a study 297 14 of dogs in referral hospitals in Canada (Weese et al., 2012) , antimicrobial therapy was 298 the only variable associated with MRSP infection, albeit related to the 30 days prior to 299 sampling. In contrast, a longitudinal study found no association between the 300 development of MRSP infection and prior antimicrobial therapy (Beck et al., 2012) . 301
Strain-specific variation or the longer time window for antimicrobial therapy in our 302 study may explain these differences. It is possible that analysis of more recent 303 antimicrobial therapy might have shown a stronger effect on MRSP selection as 304 adaption to different niches may occur more rapidly than anticipated. Alternatively, 305 MRSP may be equally well adapted to canine skin as MSSP with little need for 306 selective pressure (Beck et al., 2012) . Infect. Dis. 51, [237] [238] [239] [240] [241] [242] [243] [244] Beco, L., Guaguère, E., Lorente Méndez, C., Noli, C., Nuttall, T., Vroom, M., 2013. 349 Suggested guidelines for using systemic antimicrobials in bacterial skin infections: part 350 2--antimicrobial choice, treatment regimens and compliance. Vet. Rec. 172, [156] [157] [158] [159] [160] 
